[Development of anti-HIV drugs targeted to the coreceptors].
Murakami
T
T
Department of Microbiology and Molecular Virology, Tokyo Medical and Dental University School of Medicine, Japan.
Yamamoto
N
N
D000595:Amino Acid Sequence; D000818:Animals; D019380:Anti-HIV Agents; D023181:Antimicrobial Cationic Peptides; D001596:Benzylamines; D018946:Chemokine CCL5 / Q000031:analogs & derivatives / Q000494:pharmacology; D000080027:Cyclams; D015497:HIV-1; D006571:Heterocyclic Compounds; D006801:Humans; D008024:Ligands; D008969:Molecular Sequence Data; D009842:Oligopeptides; D010455:Peptides; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors
D019380:Anti-HIV Agents; D023181:Antimicrobial Cationic Peptides; D001596:Benzylamines; D018946:Chemokine CCL5; D000080027:Cyclams; D006571:Heterocyclic Compounds; D008024:Ligands; C094365:N-alpha-acetyl-nona-D-arginine amide acetate; D009842:Oligopeptides; D010455:Peptides; D019707:Receptors, Chemokine; C076963:T22 protein, synthetic; C088327:plerixafor